Changeflow GovPing Healthcare & Life Sciences EP4238597A2 Drug Delivery Device with Audible I...
Routine Rule Added Final

EP4238597A2 Drug Delivery Device with Audible Indicator

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

European Patent EP4238597A2 was published on April 15, 2026 by the European Patent Office. The patent, filed by Sanofi-Aventis Deutschland GmbH, covers a drug delivery device with an audible indicator mechanism. Inventors are MOSEBACH, Carsten and KEMP, Thomas Mark, with IPC classifications A61M 5/24 and A61M 5/20.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

European Patent EP4238597A2 has been published by the EPO, granting patent protection for a drug delivery device incorporating an audible indicator. The applicant is Sanofi-Aventis Deutschland GmbH with inventors MOSEBACH, Carsten and KEMP, Thomas Mark. The patent is classified under IPC categories A61M 5/24 and A61M 5/20.

Affected parties including pharmaceutical companies and medical device manufacturers developing drug delivery systems should be aware of this intellectual property landscape development. The patent provides Sanofi-Aventis with exclusive rights in the designated contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR) for the claimed audible indicator mechanism in drug delivery devices.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DRUG DELIVERY DEVICE WITH AUDIBLE INDICATOR

Publication EP4238597A2 Kind: A2 Apr 15, 2026

Applicants

Sanofi-Aventis Deutschland GmbH

Inventors

MOSEBACH, Carsten, KEMP, Thomas Mark

IPC Classifications

A61M 5/24 20060101AFI20230919BHEP A61M 5/20 20060101ALI20230919BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4238597A2

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant Drug delivery device
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!